Resource Logo
Business Wire

Research and Markets: Global HIV Drug Pipeline Capsule 2012: highlighting key research and development activities across the globe




 

Business Wire - January 10, 2012

DUBLIN - Research and Markets (http://www.researchandmarkets.com/research/b0a7b0/global_hiv_drug_pi) has announced the addition of the "Global HIV Drug Pipeline Capsule - 2012" report to their offering.

Fore Pharma's latest report Global HIV Drug Pipeline Capsule - 2012 is an outline of all the key research and development (R&D) activities of the global HIV drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered/preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the HIV drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report: HIV: Overview HIV Drug Pipeline Overview HIV Phase 3 Clinical Trial Drug Pipeline Insights HIV Phase 2 Clinical Trial Drug Pipeline Insights HIV Phase 1 Clinical Trial Drug Pipeline Insights HIV Preclinical Research Drug Pipeline Insights HIV Drug Discovery Pipeline Insights Geographic Landscape of HIV R&D Activities HIV R&D Activities in North America HIV R&D Activities in Europe Licensing Activities / Partnerships in the Global HIV Drug Market For more information visit http://www.researchandmarkets.com/research/b0a7b0/global_hiv_drug_pi Contacts Research and Markets Laura Wood, Senior Manager, press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716



 


Copyright © 2012 -Business Wire, Publisher. All rights reserved to Business Wire.Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. Business Wire.

Information in this article was accurate in January 10, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.